Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Liver stem cells and their implication in hepatocellular and cholangiocarcinoma

Abstract

In the liver, several cell types have the longevity that is needed to be the cell of origin of a cancer: hepatocytes, cholangiocytes and progenitor cells. The latter are located in the most peripheral branches of the biliary tree, the ductules and canals of Hering. The most important risk factors for liver cancer are chronic viral hepatitis B and C and alcoholic and non-alcoholic steatohepatitis. In these and other chronic liver diseases, progenitor cell activation is seen, rendering them a target cell population for carcinogenesis. The degree of activation is positively correlated with the inflammatory activity and the stage of the disease. Recently, it has been shown that in the cirrhotic stage of most chronic liver diseases, the hepatocytes become senescent owing to telomere shortening. This makes it even more plausible that at least part of the hepatocellular carcinomas originate from a progenitor cell. Hepatocellular carcinomas expressing progenitor cell/ductular markers like cytokeratin 19 have a more aggressive clinical course. It is therefore important to recognize this entity.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Alison MR, Lovell MJ . (2005). Cell Prolif 38: 407–421.

  • Alison MR, Golding M, Sarraf CE, Edwards RJ, Lalani EN . (1996). Gastroenterology 110: 1182–1190.

  • Ding SJ, Li Y, Tan YX, Jiang MR, Tian B, Liu YK et al. (2004). Mol Cell Proteomics 3: 73–81.

  • Dumble ML, Croager EJ, Yeoh GC, Quail EA . (2002). Carcinogenesis 23: 435–445.

  • Falkowski O, An HJ, Ianus IA, Chiriboga L, Yee H, West AB et al. (2003). J Hepatol 39: 357–364.

  • Fiegel HC, Gluer S, Roth B, Rischewski J, von Schweinitz D, Ure B et al. (2004). J Histochem Cytochem 52: 1495–1501.

  • Hixson DC, Brown J, McBride AC, Affigne S . (2000). Exp Mol Pathol 68: 152–169.

  • Hsia CC, Evarts RP, Nakatsukasa H, Marsden ER, Thorgeirsson SS . (1992). Hepatology 16: 1327–1333.

  • Libbrecht L, Desmet V, Van Damme B, Roskams T . (2000). J Pathol 192: 373–378.

  • Libbrecht L, Desmet V, Roskams T . (2005). Liver Int 25: 16–27.

  • Lowes KN, Brennan BA, Yeoh GC, Olynyk JK . (1999). Am J Pathol 154: 537–541.

  • Marshall A, Rushbrook S, Davies SE, Morris LS, Scott IS, Vowler SL et al. (2005). Gastroenterology 128: 33–42.

  • Nomoto K, Tsuneyama K, Cheng C, Takahashi H, Hori R, Murai Y et al. (2006). Pathol Res Pract 202: 71–76.

  • Roskams T, Desmet V . (1998). Semin Diagn Pathol 15: 259–269.

  • Roskams T, Libbrecht L, Desmet V . (2003a). Semin Liver Dis 23: 385–396.

  • Roskams T, Yang SQ, Koteish A, Durnez A, DeVos R, Huang X et al. (2003b). Am J Pathol 163: 1301–1311.

  • Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P et al. (2004). Hepatology 39: 1739–1745.

  • Ruck P, Xiao J-C, Kaiserling E . (1996). Am J Pathol 148: 321–329.

  • Sell S . (2004). Crit Rev Oncol Hematol 51: 1–28.

  • Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H et al. (2003). Cancer Sci 94: 851–877.

  • van Eyken P, Sciot R, Paterson A, Callea F, Kew MC, Desmet VJ . (1988). Hum Pathol 12: 562–568.

  • Wiemann SU, Satyanarayana A, Tsahuridu M, Tillmann HL, Zender L, Klempnauer J et al. (2002). FASEB J 16: 935–942.

  • Wilson JW, Leduc EH . (1958). J Pathol Bacteriol 76: 441–449.

  • Wu PC, Lai VC, Fang JW, Gerber MA, Lai CL, Lau JY . (1999). J Hepatol 31: 965–966.

  • Xiao JC, Ruck P, Adam A, Wang TX, Kaiserling E . (2003). Histopathology 42: 141–149.

  • Yang S, Koteish A, Lin H, Huang J, Roskams T, Dawson V et al. (2004). Hepatology 39: 403–411.

  • Yoon DS, Jeong J, Park YN, Kim KS, Kwon SW, Chi HS et al. (1999). Yonsei Med J 40: 472–477.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Roskams.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roskams, T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 25, 3818–3822 (2006). https://doi.org/10.1038/sj.onc.1209558

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209558

Keywords

This article is cited by

Search

Quick links